Humoral immunity after hematopoietic stem cell transplantation: evaluation by B-cell receptor repertoire analysis
International Journal of Hematology · 2025
DOI: 10.1007/s12185-025-04042-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hematology, 2025. Verfasst von Sakuya Matsumoto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Immunity, Humoral, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Kobe University.
Abstract (Originalsprache)
Immunity acquired before hematopoietic stem cell transplantation (HSCT) may decrease or disappear following HSCT, and it is unclear whether the first vaccination after HSCT in patients with an antigen exposure history before HSCT elicits a primary or secondary immune response. The Quantification of Antigen-Specific Antibody Sequence (QASAS) method enables real-time assessment of responses to SARS-CoV-2 antigen exposure through B-cell receptor (BCR) repertoire analysis. Using this method, we evaluated the disappearance of immunological memory after HSCT. First, in individuals without hematologic disorders, primary SARS-CoV-2 antigen exposure elicited no immune response at 7 days post-exposure but demonstrated activation between 14 to 21 days. In contrast, repeated exposure elicited early responses (secondary immune responses) at 7 days post-exposure. We then enrolled HSCT patients with pre-HSCT SARS-CoV-2 antigen exposure history and collected samples before and after vaccination. Despite prior exposure history, patients receiving their first vaccination after HSCT showed no response around 7 days post-exposure but responded at 14 days. In conclusion, even with pre-HSCT antigen exposure, the first vaccination after HSCT induced a primary immune response. This demonstrates that first vaccination after HSCT should be considered to induce a primary immune response, regardless of previous infection or vaccination history.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan.
- Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan. yohei@med.kobe-u.ac.jp.
- Translational Research Dept. Maruho Co., Ltd., Kyoto, Japan.
- Division of Infection Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan.
- Cancer Center, Kobe University Hospital, Kobe, Japan.
Förderung
- JSPS KAKENHI
- Kobe University
Zitieren
APA
Matsumoto, S., Funakoshi, Y., Yakushijin, K., Matsutani, T., Okazoe-Hirakawa, Y., Ohji, G., Koyama, T., Nagatani, Y., Kurata, K., Kimbara, S., Kiyota, N., & Minami, H. (2025). Humoral immunity after hematopoietic stem cell transplantation: evaluation by B-cell receptor repertoire analysis. International Journal of Hematology. https://doi.org/10.1007/s12185-025-04042-9
Vancouver
Matsumoto S, Funakoshi Y, Yakushijin K, Matsutani T, Okazoe-Hirakawa Y, Ohji G, et al. Humoral immunity after hematopoietic stem cell transplantation: evaluation by B-cell receptor repertoire analysis. International Journal of Hematology. 2025. doi:10.1007/s12185-025-04042-9
BibTeX
@article{Matsumoto2025,
author = {Matsumoto, Sakuya and Funakoshi, Yohei and Yakushijin, Kimikazu and Matsutani, Takaji and Okazoe-Hirakawa, Yuri and Ohji, Goh and Koyama, Taiji and Nagatani, Yoshiaki and Kurata, Keiji and Kimbara, Shiro and Kiyota, Naomi and Minami, Hironobu},
title = {Humoral immunity after hematopoietic stem cell transplantation: evaluation by B-cell receptor repertoire analysis},
journal = {International Journal of Hematology},
year = {2025},
doi = {10.1007/s12185-025-04042-9}
}
EUVIMED